DCS, a novel classifier system based on disulfidptosis reveals tumor microenvironment heterogeneity and guides frontline therapy for clear cell renal carcinoma-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

DCS, a novel classifier system based on disulfidptosis reveals tumor microenvironment heterogeneity and guides frontline therapy for clear cell renal carcinoma

Published:2024-09 Issue:3 Volume:4 Page:263-279
ISSN:2667-0054
Container-title:Journal of the National Cancer Center
language:en
Short-container-title:Journal of the National Cancer Center

Author:

Jiang Aimin,Liu Wenqiang,Liu Ying,Hu Junyi,Zhu Baohua,Fang Yu,Zhao Xuenan,Qu Le,Lu Juan,Liu Bing,Qi Lin,Cai Chen,Luo Peng,Wang Linhui^ORCID

Funder

Universidade de Macau

National Natural Science Foundation of China

Publisher

Elsevier BV

Reference79 articles.

1. Cancer statistics, 2022;Siegel;CA Cancer J Clin,2022

2. Cancer statistics, 2024;Siegel;CA Cancer J Clin,2024

3. European association of urology guidelines on renal cell carcinoma: the 2022 update;Ljungberg;Eur Urol,2022

4. Cancer statistics in China and United States, 2022: profiles, trends, and determinants;Xia;Chin Med J,2022

5. Cancer incidence and mortality in China, 2022 Cancer incidence and mortality in China, 2022;Han;J Natl Cancer Cent,2024

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP